CSTL ▼ -0.1% - Castle Biosciences, Inc.
$CSTL CSTL - New Study Shows That TissueCypher® Changed Management at an Expert Surgery Center in 90% of Patients With Non-Dysplastic Barrett's Esophagus
28-SEP-2026 07:01 AM ET
Share this post
More filings for $CSTL
CSTL ▲ +0.5% - Castle Biosciences, Inc.Oct 15, 2026CSTL ▼ -5.0% - Castle Biosciences, Inc.Oct 12, 2026CSTL ▲ +1.9% - Castle Biosciences, Inc.Sep 30, 2026CSTL ▼ -0.1% - Castle Biosciences, Inc.Sep 28, 2026CSTL ▼ -0.3% - Castle Biosciences, Inc.Sep 24, 2026CSTL ▼ -1.1% - Castle Biosciences, Inc.Sep 9, 2026
View full $CSTL filing history →💬 Comments
Loading comments…
Leave a comment